Preconception care, prenatal care, and postpartum bonding in women with substance use
- PMID: 37822612
- PMCID: PMC10562804
- DOI: 10.1016/j.heliyon.2023.e20528
Preconception care, prenatal care, and postpartum bonding in women with substance use
Abstract
Background: The status of care in the preconception and pregnancy periods in women who use substances can have an impact on maternal and neonatal health. This study aimed to assess the provision of preconception care, prenatal care, and postnatal mother-to-child bonding among pregnant women who use substances.
Methods: An ambidirectional cohort study was conducted, involving 69 pregnant women who reported substance use and had it confirmed using a ten-parameter panel kit (M10T) manufactured by Hannan Teb Pars Company. These women were selected from a referral maternity hospital between January and December 2020, using a convenience sampling method. Sociodemographic information, obstetric and medical history, and information about preconception and prenatal care were collected. All maternal and neonatal outcomes were recorded from the time of admission to the time of discharge for both the mothers and their neonates. Neonatal abstinence syndrome and mother-to-child bonding were assessed using modified Finnegan's neonatal abstinence tool and a postpartum bonding questionnaire, respectively. The data were analyzed using descriptive and inferential tests using SPSS software version 22.
Result: The mean age of the women was 32.8 ± 5.7 years. The mean duration of substance use was 5.1 ± 3.5 years. 48% of the pregnancies were reported as unwanted. A total of 94.2% and 50.7% of pregnant women did not receive preconception care and prenatal care, respectively. There was no association between pregnancy wantedness and receiving preconception care (P = 0.287), but a significant association was observed for prenatal care (P < 0.001). 31% of the mothers experienced a mother-to-child bonding disorder, with 75% of those who had unwanted pregnancies reporting such a disorder.
Conclusion: The findings of this study indicate that the majority of pregnant women who use substances did not receive preconception care, and prenatal care was inadequate with fewer visits than recommended. One-third of the pregnant women who use substances experienced a mother-to-child bonding disorder. It was also observed that women with unwanted pregnancies had poorer perinatal care and mother-to-child bonding.
Keywords: Attachment; Mother-infant Interaction; Preconception care; Pregnancy; Substance use.
© 2023 The Authors.
Conflict of interest statement
The authors declare no conflict of interest.The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004.MMWR Surveill Summ. 2007 Dec 14;56(10):1-35. MMWR Surveill Summ. 2007. PMID: 18075488
-
Psychometric properties of the Postpartum Bonding Questionnaire and correlates of mother-infant bonding impairment in Italian new mothers.Midwifery. 2017 Dec;55:15-22. doi: 10.1016/j.midw.2017.08.011. Epub 2017 Sep 1. Midwifery. 2017. PMID: 28915376
-
Level of mother-baby bonding and influencing factors during pregnancy and postpartum period.Psychiatr Danub. 2018 Dec;30(4):433-440. doi: 10.24869/psyd.2018.433. Psychiatr Danub. 2018. PMID: 30439803
-
Correlates of prenatal and postnatal mother-to-infant bonding quality: A systematic review.PLoS One. 2019 Sep 24;14(9):e0222998. doi: 10.1371/journal.pone.0222998. eCollection 2019. PLoS One. 2019. PMID: 31550274 Free PMC article.
-
Type 1 Diabetes: Management in Women From Preconception to Postpartum.J Clin Endocrinol Metab. 2021 Mar 25;106(4):952-967. doi: 10.1210/clinem/dgaa931. J Clin Endocrinol Metab. 2021. PMID: 33331893
References
-
- The United Nations Office on Drugs and Crime (UNODC) World Drug Report; 2021. Booklet 2-Global Overview of Drug Demand and Drug Supply.https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdf Accessed 10 May 2022.
-
- World Health Organization (WHO) World Health Organization. Regional Office for the Eastern Mediterranean; 2017. Atlas: Substance Use in the Eastern Mediterranean Region 2015.https://apps.who.int/iris/handle/10665/254675
-
- Moradinazar M., Najafi F., Jalilian F., Pasdar Y., Hamzeh B., Shakiba E., et al. Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey. Subst. Abuse Treat. Prev. Pol. 2020;15:39. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous